SynthesisFrontiers in medical technology2026
Reported best practices for effective risk management of medical devices: a scoping review.
Synthesis in Frontiers in medical technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Risk management (RM) is an essential element for developing safe technologies and frequently a requirement by the regulators. The practice of RM spans from pre-to-post market stages, starting from product development and continuing after product launch. Technological advancements and shifting demands in healthcare led to rapid growth of new technologies such as AI, robotics and point of care diagnostics, presenting many unknowns to the RM process. This study aims to review best practices in medical device RM, highlight gaps and ambiguities in knowledge and identify priorities for future research. A thorough literature review was conducted in June 2025 in two parts: (A) assessment of official updated regulatory documents and guidelines for Medical Devices (MDs), and (B) review published literature for reported best practices in RM of MDs. Part A of the search focused on official regulatory agencies, and Part B of the search was conducted on OVID, Embase, Medline, PubMed, Engineering Village, Scopus, and Google Scholar. A 10-year and English as language limit was applied only for part B. Our search found 147 publications (16 were guidelines from regulatory agencies and 131 were from peer reviewed literature). A total of one regulatory document and 11 studies met the inclusion criteria. Step (A) ISO 14971 was the only regulatory document that explicitly described a structured process for RM. Step (B) Although no single best practice was identified, several recurring themes emerged. Significant best practices suggest the use of hybrid or multi-component frameworks (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.